Sunday, 25 August 2019

Vaccines News

  • Protein Sciences, UNIGEN to source Flublok Influenza Vaccine from Japan

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 16 Feb, 2016

    Tokyo: North American pharmaceutical companies Protein Sciences Corporation and UMN Pharma Inc. have announced that Protein Sciences and UNIGEN Inc., a joint venture of UMN and IHI Corporat...Read more

  • Teva recalls amikacin sulfate injection

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2016

    Singapore: Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP, 1 gram/4mL (250 mg/mL) vials due to the potential presence of particulate matt...Read more

  • ABIVAX to market typhoid, meningococcus vaccines in Asia

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2014

    Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, has collaborated with Finlay Institute, Hava...Read more

  • Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2016

    Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the next decade, rising from approximately $640 million in 2014 to over $2....Read more

  • Bill & Melinda Gates Foundation supports Takeda with $38 m to eradicate polio

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 May, 2016

    Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With th...Read more

  • Merck gets FDA nod for Bridion

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Dec, 2015

    Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium) for the reversa...Read more

  • BioDiem gets hepatitis vaccine tech from Canberra univ

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to license a novel vaccine technology from the University of Canberra, expan...Read more

  • Infect mosquitoes with Wolbachia, stop diseases

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 11 Apr, 2013

    Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

  • Takeda close to releasing Norovirus vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies on a vaccine against norovirus, by the end of this year. Takeda's vacc...Read more

  • China to set up a new vaccine tracking system

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 Apr, 2016

    Singapore: According to a recent decision publicized by the Chinese government, wholesalers will no longer be allowed to trade vaccines in the country. The decision comes as a huge scandal ...Read more

  • Yisheng BioPharma gets positive result in rabies vaccine trial

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

    Singapore: Yisheng Biopharma, China based biopharmaceutical company, has recieved positive topline results from Phase I clinical trial of PIKA rabies vaccine, an investigational vaccine des...Read more

  • China's Hualan Bio gets WHO nod for influenza vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

    Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza vaccine and is taken into UN purchase plan. Flu is one of the most s...Read more

  • Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

    Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

  • German firm proceeds on ebola vaccine trial

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2015

    Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the clinical trial of its investigational vaccine against Ebola virus diseas...Read more

  • Merck's Ebola vaccine found promising in clinical trials

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2015

    Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "highly effective," in clinical trials. The vaccine was tested on more th...Read more

  • Teva recalls Adrucil injection for potential foriegn particle presence

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Jul, 2015

    Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential presence of particulate matter identified as aggregate of silicone rubber...Read more

  • Drug resistance keeps malaria threat alive in India

    Vaccines |  Analysis | By Rahul Koul Koul | 0 Comment | 02 Jul, 2012

    The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 percent, says a report by ORG IMS in Nov 2011. According to statistics...Read more

  • New vaccine against Hepatatis B developed by Cuba

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2015

    Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNasvac, developed in cooperation French company Abivax, is currently und...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls